Peter W. F. Wilson

TL;DR: The Framingham 10-year CHD risk prediction model may not identify subjects with low short-term but high lifetime risk for CHD, likely due to changes in risk factor status over time, and further work is needed to generate multivariate risk models that can reliably predict lifetime risk.

TL;DR: NIDDM and blood pressure interacted such that diagnosis and duration of NIDDM were associated with greater risk of poor performance on tests of visual memory and on the composite score for hypertensive subjects.

TL;DR: This study represents the first report on the impact of this mutation on CHD in men from the general population, and it is concluded that the S447X variant may confer significant protection against high TG levels, low HDL‐C, and prematureCHD in these subjects.

TL;DR: Examining the original Framingham Heart Study cohort to determine whether short stature is associated with all-cause mortality, cardiovascular disease mortality, and myocardial infarction after adjusting for age and other traditional coronary heart disease risk factors found it was not associated with increased risk for all- Cause or cardiovascular mortality in either sex.

TL;DR: Higher AEL may not be protective against cardiovascular events in LMICs, particularly in women, in contrast to HICs.